Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE)
Sponsor: Takeda
Summary
The main aim of this study is to compare the HAE attacks (both total and those requiring on-demand treatment) in the 12 months before and up to 24 months after initiation of treatment with lanadelumab. This study is conducted in the United Kingdom where participants were treated or about to be treated with landelumab according to their routine practice at hospitals. Data will be directly collected from participants via study diaries, questionnaires, their medical records, and study doctors treating them. Participants will be contacted every 3 months during study participation (via phone).
Official title: Demographic and Clinical Characteristics, Treatment Patterns, and Real-world Effectiveness of Lanadelumab in Patients With Hereditary Angioedema Type I or II in the United Kingdom: an Ambispective Cohort Study
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2023-06-29
Completion Date
2026-12-31
Last Updated
2025-11-20
Healthy Volunteers
No
Conditions
Interventions
No Intervention
As it is an observational study, no intervention is administered in this study.
Locations (1)
Barts Health NHS Trust
London, England, United Kingdom